Microfluidic point-of-care (POC) devices in early diagnosis: A review of opportunities and challenges
SM Yang, S Lv, W Zhang, Y Cui - Sensors, 2022 - mdpi.com
The early diagnosis of infectious diseases is critical because it can greatly increase recovery
rates and prevent the spread of diseases such as COVID-19; however, in many areas with …
rates and prevent the spread of diseases such as COVID-19; however, in many areas with …
Antibody-based immunotherapeutics and use of convalescent plasma to counter COVID-19: advances and prospects
ABSTRACT Introduction Coronavirus disease 2019 (COVID-19) has spread to several
countries globally. Currently, there is no specific drug or vaccine available for managing …
countries globally. Currently, there is no specific drug or vaccine available for managing …
Neutralizing antibody responses to SARS-CoV-2 in COVID-19 patients
GR Deshpande, GN Sapkal, BN Tilekar… - Indian Journal of …, 2020 - journals.lww.com
Methods: A total of 343 blood samples (89 positive, 58 negative for SARS-CoV-2 and 17
cross-reactive and 179 serum from healthy individuals) were collected and tested by MNT …
cross-reactive and 179 serum from healthy individuals) were collected and tested by MNT …
Passive immunity for coronavirus disease 2019: a commentary on therapeutic aspects including convalescent plasma
PF Lindholm, G Ramsey… - Seminars in thrombosis …, 2020 - thieme-connect.com
In the ongoing pandemic of coronavirus disease 2019 (COVID-19), the novel virus SARS-
CoV-2 (severe acute respiratory syndrome coronavirus 2) is infecting a naïve population …
CoV-2 (severe acute respiratory syndrome coronavirus 2) is infecting a naïve population …
Bovine serum albumin nanoparticles containing Poly (I: C) can enhance the neutralizing antibody response induced by envelope protein of Orthoflavivirus zikaense
R Piva-Amaral, GAP de Souza, JCVV Júnior… - International …, 2024 - Elsevier
Since the Orthoflavivirus zikaense (ZIKV) has been considered a risk for Zika congenital
syndrome development, developing a safe and effective vaccine has become a high priority …
syndrome development, developing a safe and effective vaccine has become a high priority …
Selection of plasma donors for the production of anti-SARS-CoV-2 immunoglobulin-based therapies: strategies for quantitative antibody measurements
BD Benites, C Costa-Lima, FBR Pinto… - … and apheresis science, 2022 - Elsevier
Even after two years of the pandemic, a completely effective treatment against SARS-CoV-2
has not yet been established. Considering this fact and the emergence of successive new …
has not yet been established. Considering this fact and the emergence of successive new …
Microfluidic Chips as Point-of-Care Testing for Develop Diagnostic Microdevices
Rapid, specific, and reliable diagnostic tests in portable, easy-to-apply systems are of great
importance for medical diagnosis, especially in emergencies such as pandemic outbreaks …
importance for medical diagnosis, especially in emergencies such as pandemic outbreaks …
[HTML][HTML] Maintaining Hemostasis and Preventing Thrombosis in COVID-19—Part I: Passive Immunity for Coronavirus Disease 2019: A Commentary on Therapeutic …
PF Lindholm, G Ramsey, HC Kwaan - Seminars in Thrombosis …, 2020 - ncbi.nlm.nih.gov
In the ongoing pandemic of coronavirus disease 2019 (COVID-19), the novel virus SARS-
CoV-2 (severe acute respiratory syndrome coronavirus 2) is infecting a naïve population …
CoV-2 (severe acute respiratory syndrome coronavirus 2) is infecting a naïve population …